*Dollar Industries Ltd.* | *CMP* Rs. 343 | *M Cap* Rs. 1945 Cr | *52 W H/L* 343/98
(Nirmal Bang Retail Research)
*Result is declining*
Revenue from Operations came at Rs. 308.3 Cr (-1.1% QoQ, 29.7% YoY) vs QoQ Rs. 311.8 Cr, YoY Rs. 237.7 Cr
EBIDTA came at Rs. 31.1 Cr (-27.9% QoQ, 48.3% YoY) vs QoQ Rs. 43.2 Cr, YoY Rs. 21 Cr
EBITDA Margin came at 10.1% vs QoQ 13.8%, YoY 8.8%
Adj. PAT came at Rs. 18.7 Cr vs QoQ Rs. 27.8 Cr, YoY Rs. 12.2 Cr
Quarter EPS is Rs. 3.3
Share is trading at P/E of 17.4x FY22E EPS
(Nirmal Bang Retail Research)
*Result is declining*
Revenue from Operations came at Rs. 308.3 Cr (-1.1% QoQ, 29.7% YoY) vs QoQ Rs. 311.8 Cr, YoY Rs. 237.7 Cr
EBIDTA came at Rs. 31.1 Cr (-27.9% QoQ, 48.3% YoY) vs QoQ Rs. 43.2 Cr, YoY Rs. 21 Cr
EBITDA Margin came at 10.1% vs QoQ 13.8%, YoY 8.8%
Adj. PAT came at Rs. 18.7 Cr vs QoQ Rs. 27.8 Cr, YoY Rs. 12.2 Cr
Quarter EPS is Rs. 3.3
Share is trading at P/E of 17.4x FY22E EPS
*Affle (India) Ltd.* | *CMP* Rs. 5225 | *M Cap* Rs. 13951 Cr | *52 W H/L* 6287/1290
(Nirmal Bang Retail Research)
*Result is ok*
Revenue from Operations came at Rs. 141.5 Cr (-6% QoQ, 76.8% YoY) vs QoQ Rs. 150.5 Cr, YoY Rs. 80 Cr
EBIDTA came at Rs. 34.2 Cr (-10.9% QoQ, 69.7% YoY) vs QoQ Rs. 38.4 Cr, YoY Rs. 20.2 Cr
EBITDA Margin came at 24.2% vs QoQ 25.5%, YoY 25.2%
Adj. PAT came at Rs. 58.5 Cr vs QoQ Rs. 30.6 Cr, YoY Rs. 15.3 Cr (Higher PAT is on account of higher Other Income)
Quarter EPS is Rs. 21.9
Share is trading at P/E of 103.1x FY22E EPS
(Nirmal Bang Retail Research)
*Result is ok*
Revenue from Operations came at Rs. 141.5 Cr (-6% QoQ, 76.8% YoY) vs QoQ Rs. 150.5 Cr, YoY Rs. 80 Cr
EBIDTA came at Rs. 34.2 Cr (-10.9% QoQ, 69.7% YoY) vs QoQ Rs. 38.4 Cr, YoY Rs. 20.2 Cr
EBITDA Margin came at 24.2% vs QoQ 25.5%, YoY 25.2%
Adj. PAT came at Rs. 58.5 Cr vs QoQ Rs. 30.6 Cr, YoY Rs. 15.3 Cr (Higher PAT is on account of higher Other Income)
Quarter EPS is Rs. 21.9
Share is trading at P/E of 103.1x FY22E EPS
*Sheela Foam Ltd.* | *CMP* Rs. 2103 | *M Cap* Rs. 10263 Cr | *52 W H/L* 2382/1222
(Nirmal Bang Retail Research)
*Result is declining*
Revenue from Operations came at Rs. 732.7 Cr (-11.3% QoQ, 45.3% YoY) vs QoQ Rs. 825.9 Cr, YoY Rs. 504.1 Cr
EBIDTA came at Rs. 84.1 Cr (-41.6% QoQ, 13.8% YoY) vs QoQ Rs. 143.9 Cr, YoY Rs. 73.9 Cr
EBITDA Margin came at 11.5% vs QoQ 17.4%, YoY 14.7%
Adj. PAT came at Rs. 58.4 Cr vs QoQ Rs. 99.3 Cr, YoY Rs. 43.7 Cr
Quarter EPS is Rs. 12
Share is trading at P/E of 34.3x FY22E EPS
(Nirmal Bang Retail Research)
*Result is declining*
Revenue from Operations came at Rs. 732.7 Cr (-11.3% QoQ, 45.3% YoY) vs QoQ Rs. 825.9 Cr, YoY Rs. 504.1 Cr
EBIDTA came at Rs. 84.1 Cr (-41.6% QoQ, 13.8% YoY) vs QoQ Rs. 143.9 Cr, YoY Rs. 73.9 Cr
EBITDA Margin came at 11.5% vs QoQ 17.4%, YoY 14.7%
Adj. PAT came at Rs. 58.4 Cr vs QoQ Rs. 99.3 Cr, YoY Rs. 43.7 Cr
Quarter EPS is Rs. 12
Share is trading at P/E of 34.3x FY22E EPS
*SH Kelkar – Q4FY21 Concall Update – Nirmal Bang Sec.*
*Outlook – Neutral for near term*
The stock is trading at 15.5x FY22E consensus earnings
• Q4 was impacted due to Covid disruptions however growth momentum is expected to continue as demand is recovering across customer segments
• The company has witnessed normalisation in demand and enquiries in both domestic and international markets
• CFF delivered healthy performance on the back of steady demand. Situation in Europe is improving – expect whole region to open by July-August.
• Maintain long term sales growth cagr of 12% however difficult to give any short-term guidance. *Q1 is expected to soft and growth is likely to resume from Q2 onwards*
• CFS + Nova – would grow by 10% CAGR
• *Gross margins are expected to maintain at ~42-43% in FY22 however it is likely to improve to 45% over 5 yrs*
• The company has been appointed as an exclusive distributor for Isobionics Santalol in India. This new fragrance ingredient is an alternative to sandalwood oil and is produced from renewable sources. Sandalwood market in India is Rs 100cr+. This deal can give further boost to growth
• *Fragrance Division* - The Company saw improved wins from existing and new large and mid-sized FMCG customers in the domestic markets. In addition, normalisation in demand across domestic and international markets assisted growth. Higher operating leverage resulted in improved yoy profitability performance
• *Flavour Division* - The segment witnessed steady offtake in domestic and European markets during the quarter. *Though margins during the quarter were impacted, the Company anticipates Qo-Q improvement, going forward*
• By investing small amount like Rs 4-5 cr can increase capacity by 30-40%. The company doesn’t need large capex
*Outlook – Neutral for near term*
The stock is trading at 15.5x FY22E consensus earnings
• Q4 was impacted due to Covid disruptions however growth momentum is expected to continue as demand is recovering across customer segments
• The company has witnessed normalisation in demand and enquiries in both domestic and international markets
• CFF delivered healthy performance on the back of steady demand. Situation in Europe is improving – expect whole region to open by July-August.
• Maintain long term sales growth cagr of 12% however difficult to give any short-term guidance. *Q1 is expected to soft and growth is likely to resume from Q2 onwards*
• CFS + Nova – would grow by 10% CAGR
• *Gross margins are expected to maintain at ~42-43% in FY22 however it is likely to improve to 45% over 5 yrs*
• The company has been appointed as an exclusive distributor for Isobionics Santalol in India. This new fragrance ingredient is an alternative to sandalwood oil and is produced from renewable sources. Sandalwood market in India is Rs 100cr+. This deal can give further boost to growth
• *Fragrance Division* - The Company saw improved wins from existing and new large and mid-sized FMCG customers in the domestic markets. In addition, normalisation in demand across domestic and international markets assisted growth. Higher operating leverage resulted in improved yoy profitability performance
• *Flavour Division* - The segment witnessed steady offtake in domestic and European markets during the quarter. *Though margins during the quarter were impacted, the Company anticipates Qo-Q improvement, going forward*
• By investing small amount like Rs 4-5 cr can increase capacity by 30-40%. The company doesn’t need large capex
👉 *LIC’s* increased the stake in the following companies
1. Rail Vikas Nigam Ltd
2. New India Assurance
3. Bajaj Auto
4. Tata Communications
5. Jammu and Kashmir Bank
6. Adani Total Gas
7. Alembic Pharmaceuticals
8. PI Industries
9. Aurobindo Pharma
10. Biocon
1. Rail Vikas Nigam Ltd
2. New India Assurance
3. Bajaj Auto
4. Tata Communications
5. Jammu and Kashmir Bank
6. Adani Total Gas
7. Alembic Pharmaceuticals
8. PI Industries
9. Aurobindo Pharma
10. Biocon
Week Ahead 🎪🎪🎪
-India to release GDP figures (Monday)
-RBI monetary policy on June 4th
-US jobs report and worldwide manufacturing and services PMIs
-US stock markets will be closed on Monday for the Memorial Day holiday
-India to release GDP figures (Monday)
-RBI monetary policy on June 4th
-US jobs report and worldwide manufacturing and services PMIs
-US stock markets will be closed on Monday for the Memorial Day holiday
⚡Three stories to begin your day:
1. Nokia refused Android
2. Yahoo refused Google
3. 97% of the Indians refused Stock Markets
And you all know what happened...
1. Nokia refused Android
2. Yahoo refused Google
3. 97% of the Indians refused Stock Markets
And you all know what happened...
Government to increase minimum air fares by around 13-15% for domestic flights w.e.f June 1.
Air fares were capped since May 2020. Government has raised air fares two times already in 2021
Air fares were capped since May 2020. Government has raised air fares two times already in 2021
Jindal Poly Q4FY21
Q4 Revenue 1,150 Cr Vs. 882 Cr YoY Vs. 1,069 Cr QoQ
FY21 Revenue: 4,082 Cr Vs. 3,546 Cr
Q4FY21 PAT: 230 Cr Vs. 139 Cr YoY Vs. 183 Cr QoQ
FY21 PAT: 788 Cr Vs. 489 Cr
EPS Q4: 52.6 Vs. 31.8 Vs. 41.8
EPS FY21: 180.6 Vs. 111.6
Net Ocf: 911 Cr Vs. 368 Cr.
Debt paid around 550 Cr.
Recommended INR 2 Per share as an dividend of FY21.
View: Very strong quarterly performance
Q4 Revenue 1,150 Cr Vs. 882 Cr YoY Vs. 1,069 Cr QoQ
FY21 Revenue: 4,082 Cr Vs. 3,546 Cr
Q4FY21 PAT: 230 Cr Vs. 139 Cr YoY Vs. 183 Cr QoQ
FY21 PAT: 788 Cr Vs. 489 Cr
EPS Q4: 52.6 Vs. 31.8 Vs. 41.8
EPS FY21: 180.6 Vs. 111.6
Net Ocf: 911 Cr Vs. 368 Cr.
Debt paid around 550 Cr.
Recommended INR 2 Per share as an dividend of FY21.
View: Very strong quarterly performance
*Time Technoplast Ltd.* | *CMP* Rs. 87 | *M Cap* Rs. 1967 Cr | *52 W H/L* 92/28
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 951.2 Cr (13.9% QoQ, 3.8% YoY) vs QoQ Rs. 834.8 Cr, YoY Rs. 916.1 Cr
EBIDTA came at Rs. 129.1 Cr (15% QoQ, 9.3% YoY) vs QoQ Rs. 112.3 Cr, YoY Rs. 118 Cr
EBITDA Margin came at 13.6% vs QoQ 13.4%, YoY 12.9%
Adj. PAT came at Rs. 52.2 Cr vs QoQ Rs. 38.5 Cr, YoY Rs. 38.3 Cr
Quarter EPS is Rs. 2.3
Share is trading at P/E of 9.2x FY22E EPS
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 951.2 Cr (13.9% QoQ, 3.8% YoY) vs QoQ Rs. 834.8 Cr, YoY Rs. 916.1 Cr
EBIDTA came at Rs. 129.1 Cr (15% QoQ, 9.3% YoY) vs QoQ Rs. 112.3 Cr, YoY Rs. 118 Cr
EBITDA Margin came at 13.6% vs QoQ 13.4%, YoY 12.9%
Adj. PAT came at Rs. 52.2 Cr vs QoQ Rs. 38.5 Cr, YoY Rs. 38.3 Cr
Quarter EPS is Rs. 2.3
Share is trading at P/E of 9.2x FY22E EPS
*KEI Industries Ltd.* | *CMP* Rs. 624 | *M Cap* Rs. 5610 Cr | *52 W H/L* 639/268
(Nirmal Bang Retail Research)
*Result inline with expectation*
Revenue from Operations came at Rs. 1246.3 Cr (8.1% QoQ, -1% YoY) vs expectation of Rs. 1222.5 Cr, QoQ Rs. 1152.9 Cr, YoY Rs. 1258.5 Cr
EBIDTA came at Rs. 141.6 Cr (10.4% QoQ, 16.2% YoY) vs expectation of Rs. 136.3 Cr, QoQ Rs. 128.3 Cr, YoY Rs. 121.8 Cr
EBITDA Margin came at 11.4% vs expectation of 11.1%, QoQ 11.1%, YoY 9.7%
Adj. PAT came at Rs. 90.1 Cr vs expectation of Rs. 90.3 Cr, QoQ Rs. 79.7 Cr, YoY Rs. 62 Cr
Quarter EPS is Rs. 10
Share is trading at P/E of 17x FY22E EPS
(Nirmal Bang Retail Research)
*Result inline with expectation*
Revenue from Operations came at Rs. 1246.3 Cr (8.1% QoQ, -1% YoY) vs expectation of Rs. 1222.5 Cr, QoQ Rs. 1152.9 Cr, YoY Rs. 1258.5 Cr
EBIDTA came at Rs. 141.6 Cr (10.4% QoQ, 16.2% YoY) vs expectation of Rs. 136.3 Cr, QoQ Rs. 128.3 Cr, YoY Rs. 121.8 Cr
EBITDA Margin came at 11.4% vs expectation of 11.1%, QoQ 11.1%, YoY 9.7%
Adj. PAT came at Rs. 90.1 Cr vs expectation of Rs. 90.3 Cr, QoQ Rs. 79.7 Cr, YoY Rs. 62 Cr
Quarter EPS is Rs. 10
Share is trading at P/E of 17x FY22E EPS
*Suprajit Engineering Ltd.* | *CMP* Rs. 264 | *M Cap* Rs. 3693 Cr | *52 W H/L* 310/107
(Nirmal Bang Retail Research)
*Result inline with expectation*
Revenue from Operations came at Rs. 513 Cr (1.1% QoQ, 31.9% YoY) vs expectation of Rs. 484.9 Cr, QoQ Rs. 507.3 Cr, YoY Rs. 389 Cr
EBIDTA came at Rs. 81.7 Cr (-5.4% QoQ, 48.8% YoY) vs expectation of Rs. 78 Cr, QoQ Rs. 86.4 Cr, YoY Rs. 54.9 Cr
EBITDA Margin came at 15.9% vs expectation of 16.1%, QoQ 17%, YoY 14.1%
Adj. PAT came at Rs. 57.5 Cr vs expectation of Rs. 48.6 Cr, QoQ Rs. 51.6 Cr, YoY Rs. 30.4 Cr
Quarter EPS is Rs. 4.1
Share is trading at P/E of 21.2x FY22E EPS
(Nirmal Bang Retail Research)
*Result inline with expectation*
Revenue from Operations came at Rs. 513 Cr (1.1% QoQ, 31.9% YoY) vs expectation of Rs. 484.9 Cr, QoQ Rs. 507.3 Cr, YoY Rs. 389 Cr
EBIDTA came at Rs. 81.7 Cr (-5.4% QoQ, 48.8% YoY) vs expectation of Rs. 78 Cr, QoQ Rs. 86.4 Cr, YoY Rs. 54.9 Cr
EBITDA Margin came at 15.9% vs expectation of 16.1%, QoQ 17%, YoY 14.1%
Adj. PAT came at Rs. 57.5 Cr vs expectation of Rs. 48.6 Cr, QoQ Rs. 51.6 Cr, YoY Rs. 30.4 Cr
Quarter EPS is Rs. 4.1
Share is trading at P/E of 21.2x FY22E EPS
*ITD Cementation India Ltd.* | *CMP* Rs. 81 | *M Cap* Rs. 1385 Cr | *52 W H/L* 94/35
(Nirmal Bang Retail Research)
*Result is ahead of expectation*
Revenue from Operations came at Rs. 983.9 Cr (24.3% QoQ, 33% YoY) vs expectation of Rs. 920.9 Cr, QoQ Rs. 791.7 Cr, YoY Rs. 739.6 Cr
EBIDTA came at Rs. 113.8 Cr (60.4% QoQ, 35.2% YoY) vs expectation of Rs. 87.6 Cr, QoQ Rs. 70.9 Cr, YoY Rs. 84.2 Cr
EBITDA Margin came at 11.6% vs expectation of 9.5%, QoQ 9%, YoY 11.4%
Adj. PAT came at Rs. 52.5 Cr vs expectation of Rs. 35.9 Cr, QoQ Rs. 30 Cr, YoY Rs. 35.5 Cr
Quarter EPS is Rs. 3.1
Share is trading at P/E of 9.9x FY22E EPS
(Nirmal Bang Retail Research)
*Result is ahead of expectation*
Revenue from Operations came at Rs. 983.9 Cr (24.3% QoQ, 33% YoY) vs expectation of Rs. 920.9 Cr, QoQ Rs. 791.7 Cr, YoY Rs. 739.6 Cr
EBIDTA came at Rs. 113.8 Cr (60.4% QoQ, 35.2% YoY) vs expectation of Rs. 87.6 Cr, QoQ Rs. 70.9 Cr, YoY Rs. 84.2 Cr
EBITDA Margin came at 11.6% vs expectation of 9.5%, QoQ 9%, YoY 11.4%
Adj. PAT came at Rs. 52.5 Cr vs expectation of Rs. 35.9 Cr, QoQ Rs. 30 Cr, YoY Rs. 35.5 Cr
Quarter EPS is Rs. 3.1
Share is trading at P/E of 9.9x FY22E EPS
👍1
*Force Motors Ltd.* | *CMP* Rs. 1249 | *M Cap* Rs. 1624 Cr | *52 W H/L* 1560/806
(Nirmal Bang Retail Research)
*Result has declined*
Revenue from Operations came at Rs. 612.5 Cr (24.7% QoQ, -6.3% YoY) vs QoQ Rs. 491.2 Cr, YoY Rs. 653.8 Cr
EBIDTA came at Rs. -36.2 Cr (-226% QoQ, -148.9% YoY) vs QoQ Rs. 28.7 Cr, YoY Rs. 74 Cr
EBITDA Margin came at -5.9% vs QoQ 5.8%, YoY 11.3%
Adj. PAT came at Rs. -53.7 Cr vs QoQ Rs. -19 Cr, YoY Rs. 25.6 Cr
Quarter EPS is Rs. -41.3
Share is trading at P/E of -13.1x TTM EPS
(Nirmal Bang Retail Research)
*Result has declined*
Revenue from Operations came at Rs. 612.5 Cr (24.7% QoQ, -6.3% YoY) vs QoQ Rs. 491.2 Cr, YoY Rs. 653.8 Cr
EBIDTA came at Rs. -36.2 Cr (-226% QoQ, -148.9% YoY) vs QoQ Rs. 28.7 Cr, YoY Rs. 74 Cr
EBITDA Margin came at -5.9% vs QoQ 5.8%, YoY 11.3%
Adj. PAT came at Rs. -53.7 Cr vs QoQ Rs. -19 Cr, YoY Rs. 25.6 Cr
Quarter EPS is Rs. -41.3
Share is trading at P/E of -13.1x TTM EPS
*Jindal Poly Films Ltd.* | *CMP* Rs. 856 | *M Cap* Rs. 3749 Cr | *52 W H/L* 941/273
(Nirmal Bang Retail Research)
*Result declining*
Revenue from Operations came at Rs. 1150.9 Cr (7.7% QoQ, 29% YoY) vs QoQ Rs. 1069 Cr, YoY Rs. 892.2 Cr
EBIDTA came at Rs. 243.6 Cr (-19.8% QoQ, 16.8% YoY) vs QoQ Rs. 303.6 Cr, YoY Rs. 208.6 Cr
EBITDA Margin came at 21.2% vs QoQ 28.4%, YoY 23.4%
Adj. PAT came at Rs. 230.9 Cr vs QoQ Rs. 197.2 Cr, YoY Rs. 165.9 Cr (Higher PAT is on account of higher other Income and negative finance cost)
Quarter EPS is Rs. 52.7
Share is trading at P/E of 4.7x TTM EPS
(Nirmal Bang Retail Research)
*Result declining*
Revenue from Operations came at Rs. 1150.9 Cr (7.7% QoQ, 29% YoY) vs QoQ Rs. 1069 Cr, YoY Rs. 892.2 Cr
EBIDTA came at Rs. 243.6 Cr (-19.8% QoQ, 16.8% YoY) vs QoQ Rs. 303.6 Cr, YoY Rs. 208.6 Cr
EBITDA Margin came at 21.2% vs QoQ 28.4%, YoY 23.4%
Adj. PAT came at Rs. 230.9 Cr vs QoQ Rs. 197.2 Cr, YoY Rs. 165.9 Cr (Higher PAT is on account of higher other Income and negative finance cost)
Quarter EPS is Rs. 52.7
Share is trading at P/E of 4.7x TTM EPS
Money Market Update
The rupee ended at 72.43 against the U.S. Dollar on Friday as compared to Thursday's closing of 72.59.
The rupee ended at 72.43 against the U.S. Dollar on Friday as compared to Thursday's closing of 72.59.
*Ashika Global Market Update*
SGX NIFTY: -44(15419) @7:05 am *Considering Friday’s closing of 15463
DOW: +64(+0.19%)
DOW FUTURES: +16(+0.04%)
HANGSENG: -92(-0.32%)
SHANGHAI COMP: -14(-0.38%)
NIKKEI: -207(-0.733)
GOLD COMEX(USD/toz): 1907.10(+0.09%)
SILVER COMEX (USD/toz): 28.08(+0.22%)
LME COPPER(USD/MT): 10258.00(+0.36%)
LME ZINC(USD/MT): 3060.00(-0.03%)
LME ALUMINIUM(USD/MT): 2483.00(+0.08%)
BRENT CRUDE(USD/bbl): 68.75(+0.04%)
WTI CRUDE OIL(USD/bbl): 66.42(+0.15%)
USDINR: 72.43(-0.21%)
DOLLAR INDEX: 90.09(+0.06%)
US 10YRS BOND YIELD: 1.58%
INDIA 10YRS BOND YIELD: 6.00%
FII: +913
DII: +1275
FII F&O: +536
BSE CASH SEGMENT TRADED VALUE (Rs Crs): 5386
NSE CASH SEGMENT TRADED VALUE(Rs Crs): 74361
NSE ADVANCE/ DECLINE: 769/1206 (0.63)
Securities in Ban Period: SUNTV
Ashika
SGX NIFTY: -44(15419) @7:05 am *Considering Friday’s closing of 15463
DOW: +64(+0.19%)
DOW FUTURES: +16(+0.04%)
HANGSENG: -92(-0.32%)
SHANGHAI COMP: -14(-0.38%)
NIKKEI: -207(-0.733)
GOLD COMEX(USD/toz): 1907.10(+0.09%)
SILVER COMEX (USD/toz): 28.08(+0.22%)
LME COPPER(USD/MT): 10258.00(+0.36%)
LME ZINC(USD/MT): 3060.00(-0.03%)
LME ALUMINIUM(USD/MT): 2483.00(+0.08%)
BRENT CRUDE(USD/bbl): 68.75(+0.04%)
WTI CRUDE OIL(USD/bbl): 66.42(+0.15%)
USDINR: 72.43(-0.21%)
DOLLAR INDEX: 90.09(+0.06%)
US 10YRS BOND YIELD: 1.58%
INDIA 10YRS BOND YIELD: 6.00%
FII: +913
DII: +1275
FII F&O: +536
BSE CASH SEGMENT TRADED VALUE (Rs Crs): 5386
NSE CASH SEGMENT TRADED VALUE(Rs Crs): 74361
NSE ADVANCE/ DECLINE: 769/1206 (0.63)
Securities in Ban Period: SUNTV
Ashika
Paytm Ipo : The board of One97 Communications, Paytm's parent firm, gives in-principle approval for an IPO, setting the stage for what is likely to be one of India's largest public offerings.Reports
Result Today
Magma Fincorp Ltd.
Jamna Auto Industries Ltd.
Apar Industries Ltd.
Kolte Patil Developers Ltd.
Chemcon Speciality Chemicals Ltd.
Panama Petrochem Ltd.
Xchanging Solutions Ltd.
Chaman Lal Setia Exports Ltd.
Nelcast Ltd.
Asian Granito India Ltd.
Tourism Finance Corporation Of India Ltd.
Man Industries (India) Ltd.
Urja Global Ltd.
Vascon Engineers Ltd.
Astron Paper & Board Mill Ltd.
Bannari Amman Spinning Mills Ltd.
TIL Ltd.
Modison Metals Ltd.
Magma Fincorp Ltd.
Jamna Auto Industries Ltd.
Apar Industries Ltd.
Kolte Patil Developers Ltd.
Chemcon Speciality Chemicals Ltd.
Panama Petrochem Ltd.
Xchanging Solutions Ltd.
Chaman Lal Setia Exports Ltd.
Nelcast Ltd.
Asian Granito India Ltd.
Tourism Finance Corporation Of India Ltd.
Man Industries (India) Ltd.
Urja Global Ltd.
Vascon Engineers Ltd.
Astron Paper & Board Mill Ltd.
Bannari Amman Spinning Mills Ltd.
TIL Ltd.
Modison Metals Ltd.
🔹 *STOCKS TO WATCH:*
ADITYA BIRLA FASHION, ACTION CONSTRUCTION, DIVI’S LAB, SUMITOMO CHEMICAL, SMS PHARMA, AFFLE INDIA, HEIDELBERGCEMENT, SUDARSHAN CHEMICAL, ITD CEMENTATION, PRATAP SNACKS, TIME TECHNO, GLENMARK, JINDAL POLY, HIMATSINGKA SEIDE, FORTIS HEALTHCARE, BOB, INDIAN BANK
Aditya Birla Fashion: Q4 Cons Net Loss 1.38b Rupees Vs Loss 1.45b (YoY); Est Loss 360m | Profit 594m (QoQ) || Q4 Revenue 18.22b Rupees Vs 18.32b (YoY)
Action Construction Equipment: Q4 Cons Net Profit 386m Rupees Vs 136m (YoY) | 309m (QoQ) || Q4 Revenue 4.57b Rupees Vs 3.05b (YoY)
Divi’s Lab: Q4 Cons Net Profit 5.02b Rupees Vs 3.88b (YoY) | 4.71b (QoQ); Est. 4.7b || Q4 Revenue 17.88b Rupees Vs 13.9b (YoY) || Recommended Final Dividend Of 20 Rupees/Share
Sumitomo Chemical India: Q4 Cons Net Profit 541m Rupees Vs 229m (YoY); Est 370m | 541m (QoQ) || Q4 Revenue 5.34b Rupees Vs 4.47b (YoY)
SMS Pharmaceuticals: Q4 Cons Net Profit 222.1m Rupees Vs 62.5m (YoY) | 183m (QoQ) || Q4 Revenue 1.71b Rupees Vs 965m (YoY) || Dividend For The Year 2020-21 At Rupees 0.30 Per Equity Share
Affle India: Q4 Cons Net Profit 585m Rupees Vs 153m (YoY) | 306m (QoQ); Est 230m || Q4 Revenue 1.41b Rupees Vs 800m (YoY)
Heidelbergcement India: Q4 Sl Net Profit 1.4b Rupees Vs 663m (YoY); Est 710m | 636m (QoQ) || Q4 Revenue 5.81b Rupees Vs 5.10b (YoY) || Recommended Dividend 8 Rupees Per Share
Sudarshan Chemical: Q4 Cons Net Profit 534.2m Rupees Vs 273m (YoY); Est 421m | 392m (QoQ) || Q4 Revenue 5.73b Rupees Vs 4.42b (YoY)
ITD Cementation: Q4 Cons Net Profit 639.7m Rupees Vs 342m (YoY); Est 360m | 340m (QoQ) || Q4 Revenue 9.84b Rupees Vs 7.4b (YoY) || Recommendation For Payment Of Dividend At Rupees 0.12 Per Equity Share
Prataap Snacks : Q4 Cons Net Profit 71.3m Rupees Vs 197.5m (YoY); Est 10m | 45.4m (QoQ) || Q4 Revenue 3.08b Rupees Vs 3.1b (YoY) || Recommended Dividend Of Rupees 0.50 Per Share
Time Technoplast: Q4 Cons Net Profit 522m Rupees Vs 383m (YoY); Est 530m | 384m (QoQ) || Q4 Revenue 9.51b Rupees Vs 9.16b (YoY) || Recommended Final Dividend Of Rupees 0.70 Per Equity Share
Glenmark Pharma: Q4 Cons Net Profit 2.34b Rupees Vs 2.2b (YoY); Est 2.4b | 2.48b (QoQ) || Q4 Revenue 28.6b Rupees Vs 27.6b (YoY) || Recommended A Final Dividend Of Rupees 2.50 Per Equity Share
Jindal Poly Films: Q4 Cons Net Profit 2.3b Rupees Vs 1.39b (YoY) | 1.84b (QoQ) || Q4 Revenue 11.51b Rupees Vs 8.82b (YoY) || Recommended Dividend Rupees 2 Per Equity Share
Himatsingka Seide: Q4 Cons Net Profit 376m Rupees Vs Loss 688m (YoY) | Profit 451m (Qoq); Est. 370m || Q4 Revenue 7.46b Rupees Vs 4.35b (YoY) || Recommended Final Dividend Of 50 Paise/Share
Fortis Healthcare: Q4 Cons Net Profit 432m Rupees Vs Loss 445m (YoY) | Profit 299m (QoQ); est. Profit 570m || Q4 Revenue 12.52b Rupees Vs 11.13b (YoY)
Bank Of Baroda: Q4 Net Loss 10.46b Rupees Vs Profit 5.06b (YoY) | 10.61b (QoQ); Est. Profit 11b || Q4 Interest Income 166.8b Rupees Vs 186.9b (YoY) || Q4 Provisions 62.6b Rupees Vs 49.2b (YoY) || Q4 Gross Npa 8.87% Vs 8.48% (QoQ) || Q4 Net Npa 3.09% Vs 2.39% (YoY)
Indian Bank: Q4 Sl Net Profit 17.09b Rupees Vs Loss 2.18b (YoY); Est Profit 5.5b | Profit 5.14b (QoQ) || Q4 Revenue 89.04b Rupees Vs 54.93b (YoY) || Q4 Provisions 28.70b Rupees Vs 14.30b (YoY) || Q4 Net Npa 3.37% Vs 2.35% (QoQ) || Q4 Gross Npa 9.85% Vs 9.04% (QoQ) || Recommends Dividend Of 2 Rupees/Share
🔹 *Earnings Today:*
Apar Industries, Asian Granito, Auro Pharma, Honeywell Auto, Ingersoll Rand, Jamna Auto, JBF Industries, Kolte-Patil, Magma Fincorp, Narayana Hruda, Prakash Industries, Shilpa Medicare, Tourism Finance, TRF, Venus Remedies
🔹 *Stocks Ban In F&O:*
Sun TV
ADITYA BIRLA FASHION, ACTION CONSTRUCTION, DIVI’S LAB, SUMITOMO CHEMICAL, SMS PHARMA, AFFLE INDIA, HEIDELBERGCEMENT, SUDARSHAN CHEMICAL, ITD CEMENTATION, PRATAP SNACKS, TIME TECHNO, GLENMARK, JINDAL POLY, HIMATSINGKA SEIDE, FORTIS HEALTHCARE, BOB, INDIAN BANK
Aditya Birla Fashion: Q4 Cons Net Loss 1.38b Rupees Vs Loss 1.45b (YoY); Est Loss 360m | Profit 594m (QoQ) || Q4 Revenue 18.22b Rupees Vs 18.32b (YoY)
Action Construction Equipment: Q4 Cons Net Profit 386m Rupees Vs 136m (YoY) | 309m (QoQ) || Q4 Revenue 4.57b Rupees Vs 3.05b (YoY)
Divi’s Lab: Q4 Cons Net Profit 5.02b Rupees Vs 3.88b (YoY) | 4.71b (QoQ); Est. 4.7b || Q4 Revenue 17.88b Rupees Vs 13.9b (YoY) || Recommended Final Dividend Of 20 Rupees/Share
Sumitomo Chemical India: Q4 Cons Net Profit 541m Rupees Vs 229m (YoY); Est 370m | 541m (QoQ) || Q4 Revenue 5.34b Rupees Vs 4.47b (YoY)
SMS Pharmaceuticals: Q4 Cons Net Profit 222.1m Rupees Vs 62.5m (YoY) | 183m (QoQ) || Q4 Revenue 1.71b Rupees Vs 965m (YoY) || Dividend For The Year 2020-21 At Rupees 0.30 Per Equity Share
Affle India: Q4 Cons Net Profit 585m Rupees Vs 153m (YoY) | 306m (QoQ); Est 230m || Q4 Revenue 1.41b Rupees Vs 800m (YoY)
Heidelbergcement India: Q4 Sl Net Profit 1.4b Rupees Vs 663m (YoY); Est 710m | 636m (QoQ) || Q4 Revenue 5.81b Rupees Vs 5.10b (YoY) || Recommended Dividend 8 Rupees Per Share
Sudarshan Chemical: Q4 Cons Net Profit 534.2m Rupees Vs 273m (YoY); Est 421m | 392m (QoQ) || Q4 Revenue 5.73b Rupees Vs 4.42b (YoY)
ITD Cementation: Q4 Cons Net Profit 639.7m Rupees Vs 342m (YoY); Est 360m | 340m (QoQ) || Q4 Revenue 9.84b Rupees Vs 7.4b (YoY) || Recommendation For Payment Of Dividend At Rupees 0.12 Per Equity Share
Prataap Snacks : Q4 Cons Net Profit 71.3m Rupees Vs 197.5m (YoY); Est 10m | 45.4m (QoQ) || Q4 Revenue 3.08b Rupees Vs 3.1b (YoY) || Recommended Dividend Of Rupees 0.50 Per Share
Time Technoplast: Q4 Cons Net Profit 522m Rupees Vs 383m (YoY); Est 530m | 384m (QoQ) || Q4 Revenue 9.51b Rupees Vs 9.16b (YoY) || Recommended Final Dividend Of Rupees 0.70 Per Equity Share
Glenmark Pharma: Q4 Cons Net Profit 2.34b Rupees Vs 2.2b (YoY); Est 2.4b | 2.48b (QoQ) || Q4 Revenue 28.6b Rupees Vs 27.6b (YoY) || Recommended A Final Dividend Of Rupees 2.50 Per Equity Share
Jindal Poly Films: Q4 Cons Net Profit 2.3b Rupees Vs 1.39b (YoY) | 1.84b (QoQ) || Q4 Revenue 11.51b Rupees Vs 8.82b (YoY) || Recommended Dividend Rupees 2 Per Equity Share
Himatsingka Seide: Q4 Cons Net Profit 376m Rupees Vs Loss 688m (YoY) | Profit 451m (Qoq); Est. 370m || Q4 Revenue 7.46b Rupees Vs 4.35b (YoY) || Recommended Final Dividend Of 50 Paise/Share
Fortis Healthcare: Q4 Cons Net Profit 432m Rupees Vs Loss 445m (YoY) | Profit 299m (QoQ); est. Profit 570m || Q4 Revenue 12.52b Rupees Vs 11.13b (YoY)
Bank Of Baroda: Q4 Net Loss 10.46b Rupees Vs Profit 5.06b (YoY) | 10.61b (QoQ); Est. Profit 11b || Q4 Interest Income 166.8b Rupees Vs 186.9b (YoY) || Q4 Provisions 62.6b Rupees Vs 49.2b (YoY) || Q4 Gross Npa 8.87% Vs 8.48% (QoQ) || Q4 Net Npa 3.09% Vs 2.39% (YoY)
Indian Bank: Q4 Sl Net Profit 17.09b Rupees Vs Loss 2.18b (YoY); Est Profit 5.5b | Profit 5.14b (QoQ) || Q4 Revenue 89.04b Rupees Vs 54.93b (YoY) || Q4 Provisions 28.70b Rupees Vs 14.30b (YoY) || Q4 Net Npa 3.37% Vs 2.35% (QoQ) || Q4 Gross Npa 9.85% Vs 9.04% (QoQ) || Recommends Dividend Of 2 Rupees/Share
🔹 *Earnings Today:*
Apar Industries, Asian Granito, Auro Pharma, Honeywell Auto, Ingersoll Rand, Jamna Auto, JBF Industries, Kolte-Patil, Magma Fincorp, Narayana Hruda, Prakash Industries, Shilpa Medicare, Tourism Finance, TRF, Venus Remedies
🔹 *Stocks Ban In F&O:*
Sun TV